Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101146768B reveals a green synthesis route for NPY Y5 antagonist intermediates using toluene and additives, offering significant cost reduction in API manufacturing.
Patent CN113735867B reveals high-yield chiral synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN108503549A details a novel one-pot synthesis for aromatic trifluoroethyl esters, offering high yields and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN110903231B details a mild TfOH-catalyzed route to 2-cyanopyrroles. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel cesium carbonate catalyzed method for high-purity chiral cyclopropyl amino acid. Reduces steps and solvent use for reliable pharmaceutical intermediate supply.
Patent CN116768904B reveals high-yield chiral synthesis for antitumor intermediates, offering significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
This report analyzes patent CN103804187B for Jacaronic Acid A synthesis offering scalable production and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN120923511A details novel synthesis for vinyl indolo cyclic compounds with high enantioselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid catalysis. Offers high ee, mild conditions, and scalable production for pharmaceutical applications.
Novel chiral phosphoric acid catalysis for high-purity anticancer intermediates. Cost-effective scale-up and reliable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN101875658B details a chromatography-free route for spiro diazepine intermediates, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Novel Pd-catalyzed method offers high yield and enantioselectivity for pharmaceutical intermediates manufacturing supply chain and significant cost reduction benefits for global buyers seeking reliability.
Novel bismuth-catalyzed route offers high yields and recyclability for asymmetric triarylmethane derivatives, reducing costs in pharmaceutical intermediate manufacturing.
Patent CN103153956A details a novel route for kinase inhibitor intermediates using Suzuki-Miyaura coupling, offering enhanced safety and yield for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis method patent CN116199614B offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel 3-step synthesis route from 1-fluorocyclopropanecarboxylic acid. Achieves >60% total yield, avoids fluoromethylation byproducts. Ideal for GPR40 agonist intermediates.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.